These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2558839)

  • 21. Octreotide--a synthetic somatostatin.
    Med Lett Drugs Ther; 1989 Jul; 31(796):66-8. PubMed ID: 2567960
    [No Abstract]   [Full Text] [Related]  

  • 22. Potential gastrointestinal uses of somatostain and its synthetic analogue octreotide.
    Grosman I; Simon D
    Am J Gastroenterol; 1990 Sep; 85(9):1061-72. PubMed ID: 1975156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
    Harris AG
    Gut; 1994; 35(3 Suppl):S1-4. PubMed ID: 7911441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors.
    Wynick D; Bloom SR
    J Clin Endocrinol Metab; 1991 Jul; 73(1):1-3. PubMed ID: 1646213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.
    Battershill PE; Clissold SP
    Drugs; 1989 Nov; 38(5):658-702. PubMed ID: 2689136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vipoma in an adolescent: treatment with a delayed-action somatostatin analog, octreotide or SMS 201-995, and surgical removal].
    Brichard B; Fiasse R; Buts JP; Clapuyt P; Maes M; Rahier J; Cornu G
    Acta Gastroenterol Belg; 1990; 53(2):188-97. PubMed ID: 2176428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral delivery of octreotide acetate in Intravail® improves uptake, half-life, and bioavailability over subcutaneous administration in male Swiss webster mice.
    Maggio ET; Grasso P
    Regul Pept; 2011 Apr; 167(2-3):233-8. PubMed ID: 21329733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of a VIPoma by continuous subcutaneous infusion of somatostatin analogue (SMS 201-995).
    Niitsu Y; Goto Y; Maeda M; Tsushima N; Watanabe N; Kohgo Y; Urushizaki I
    Aliment Pharmacol Ther; 1988 Jun; 2(3):269-79. PubMed ID: 2856504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Octreotide: a synthetic analog of somatostatin.
    Rosenberg JM
    Drug Intell Clin Pharm; 1988 Oct; 22(10):748-54. PubMed ID: 3068036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The somatostatin analog SMS 201-995 in long-term treatment of vipoma].
    Christensen C
    Ugeskr Laeger; 1990 Dec; 152(51):3851-3. PubMed ID: 2177234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pediatric case of anaphylaxis due to octreotide.
    Azkur D; Yoldas T; Toyran M; Kocabas CN
    Asian Pac J Allergy Immunol; 2011 Dec; 29(4):361-3. PubMed ID: 22299317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of endocrine and nonendocrine secretory diarrheal states with Sandostatin.
    Gaginella TS; O'Dorisio TM; Fassler JE; Mekhjian HS
    Metabolism; 1990 Sep; 39(9 Suppl 2):172-5. PubMed ID: 2205786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical application of somatostatin-analogue].
    Tanaka K; Itoh S; Shimizu N
    Nihon Rinsho; 1990 May; 48(5):1084-8. PubMed ID: 2165538
    [No Abstract]   [Full Text] [Related]  

  • 34. Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport.
    Santangelo WC; O'Dorisio TM; Kim JG; Severino G; Krejs GJ
    Ann Intern Med; 1985 Sep; 103(3):363-7. PubMed ID: 2862821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism.
    Laje P; Halaby L; Adzick NS; Stanley CA
    Pediatr Diabetes; 2010 Mar; 11(2):142-7. PubMed ID: 19558634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Octreotide: a long-acting somatostatin analog.
    Brown NJ
    Am J Med Sci; 1990 Oct; 300(4):267-73. PubMed ID: 2248280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical use of the long acting somatostatin analogue octreotide in pediatrics.
    Tauber MT; Harris AG; Rochiccioli P
    Eur J Pediatr; 1994 May; 153(5):304-10. PubMed ID: 8033916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between somatostatin analog injections.
    Gezer E; Demirhan Y; Selek A; Cantürk Z; Çetinarslan B; Sözen M; Köksalan D; Karatoprak AP
    Rev Assoc Med Bras (1992); 2022 Apr; 68(4):514-518. PubMed ID: 35649076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future medical prospects for Sandostatin.
    Harris AG
    Metabolism; 1990 Sep; 39(9 Suppl 2):180-5. PubMed ID: 2205787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four year treatment with a long acting somatostatin analogue in a patient with Verner-Morrison syndrome.
    Brunani A; Crespi C; De Martin M; Dubini A; Piolini M; Cavagnini F
    J Endocrinol Invest; 1991 Sep; 14(8):685-9. PubMed ID: 1663530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.